Regulatory T Cell Dysfunction and Immunotherapeutic Breakthroughs in Type 1 Diabetes
January 2026
in “
Frontiers in Endocrinology
”
Studysummary This review discusses the impaired functionality of regulatory T cells in the pancreas during the development of Type 1 diabetes, highlighting their role in disease pathogenesis, potential of Treg-based therapies, and challenges in clinical applications.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on public-pages-files-2025.frontiersin.org →